Verona Pharma plc
VRNADelisted Oct 7, 2025- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001657312
Verona Pharma plc was delisted on Oct 7, 2025; its insiders filed their last Form 4 on Oct 8, 2025; 243 institutions reported holding it in 13F filings for Q3 2025, worth $8.57B in total; superinvestors Duquesne Family Office and Soros Fund Management held it.
Holders of 5% or more of VRNA
Holders whose latest Schedule 13D or 13G filing reports 5% or more of Verona Pharma plc, largest stake first. The change is against the holder's previous filing.
| Holder | Latest form | Stake | Change | First filed | Latest filing | Filing |
|---|---|---|---|---|---|---|
| Janus Henderson Group PLC | 13G/A | 7.20%6.13M shares | +0.70 ppfrom 6.50% | May 14, 20252 filings | Aug 14, 2025 | SEC |
| Perceptive Advisors LLC | 13G/A | 6.40%5.51M shares | – | Aug 14, 20251 filing | Aug 14, 2025 | SEC |
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
8 Schedule 13D and 13G filings on Verona Pharma plc, newest first, including old-format filings without a stake.
| Filed (ET) | Filer | Form | Stake | Change | Event date | Filing |
|---|---|---|---|---|---|---|
| Nov 14, 20254:27 PM ET | Pentwater Capital Management LPand 1 other | 13G | 0.00%0 shares | NewBelow 5% | Sep 30, 2025 | SEC |
| Nov 14, 20254:00 PM ET | Perceptive Advisors LLCand 2 others | 13G/A | 0.00%0 shares | −6.40 ppfrom 6.40%Below 5% | Sep 30, 2025 | SEC |
| Nov 14, 202510:24 AM ET | Janus Henderson Group PLC | 13G/A | 1.20%1.01M shares | −6.00 ppfrom 7.20%Below 5% | Sep 30, 2025 | SEC |
| Aug 14, 20256:14 PM ET | Ra Capital Management, L.P.and 3 others | 13G/A | 0.70%593.7K shares | −6.40 ppfrom 7.10%Below 5% | Jun 30, 2025 | SEC |
| Aug 14, 20254:15 PM ET | Perceptive Advisors LLCand 2 others | 13G/A | 6.40%5.51M shares | – | Jun 30, 2025 | SEC |
| Aug 14, 202511:27 AM ET | Janus Henderson Group PLC | 13G/A | 7.20%6.13M shares | +0.70 ppfrom 6.50% | Jun 30, 2025 | SEC |
| May 15, 20254:49 PM ET | Ra Capital Management, L.P.and 3 others | 13G/A | 7.10%6.01M shares | −1.80 ppfrom 8.90% | Mar 31, 2025 | SEC |
| May 14, 202511:47 AM ET | Janus Henderson Group PLC | 13G | 6.50%5.54M shares | New | Mar 31, 2025 | SEC |
| Feb 14, 20256:43 PM ET | Ra Capital Management, L.P.and 3 others | 13G/A | 8.90%7.78M shares | – | Dec 31, 2024 | SEC |
| Feb 14, 20254:15 PM ET | Maverick Capital Ltdand 2 othersSuperinvestorMaverick Capital | 13G/A | 3.80%25.0M shares | –Below 5% | Dec 31, 2024 | SEC |
| Jan 21, 20258:33 PM ET | Growth Equity Opportunities Fund IV, LLCand 16 others | 13D/A | 4.99%32.7M shares | –Below 5% | Jan 16, 2025 | SEC |
Form 144: proposed insider sales
Notices from officers, directors and other affiliates planning to sell Verona Pharma plc shares.
No Form 144 notices for Verona Pharma plc are on file.